Expired Canadian patentCanada
Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
CA 2429625 C · Owner: Sackstein, Robert · Inventors: Sackstein, Robert
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention feature methods and compositions for treating hematopoietic disorders, inflammatory conditions, and cancer and providing stem cell therapy in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2001 and granted May 1, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 18, 2001
GrantedMay 1, 2012
Term endedOctober 18, 2021
Patent numberCA 2429625 C
Classification (IPC)C07K14/70 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.